Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.07% |
| Dec 31, 2025 | 122.47% |
| Sep 30, 2025 | 121.88% |
| Jun 30, 2025 | 117.48% |
| Mar 31, 2025 | 139.90% |
| Dec 31, 2024 | 139.35% |
| Sep 30, 2024 | 135.28% |
| Jun 30, 2024 | 129.60% |
| Mar 31, 2024 | 131.29% |
| Dec 31, 2023 | 127.04% |
| Mar 31, 2023 | -68.55% |
| Dec 31, 2022 | 129.86% |
| Sep 30, 2022 | -17.01% |
| Jun 30, 2022 | -14.46% |
| Mar 31, 2022 | 16.52% |
| Dec 31, 2021 | 16.92% |
| Sep 30, 2021 | 8.79% |
| Jun 30, 2021 | -3.16% |
| Mar 31, 2021 | -10.95% |
| Dec 31, 2020 | -9.11% |
| Sep 30, 2020 | -9.14% |
| Jun 30, 2020 | 26.41% |
| Mar 31, 2020 | -4.52% |
| Dec 31, 2019 | -19.71% |
| Sep 30, 2019 | -6.84% |
| Jun 30, 2019 | -7.27% |
| Mar 31, 2019 | -10.24% |
| Dec 31, 2018 | -10.76% |
| Sep 30, 2018 | -19.36% |
| Jun 30, 2018 | -20.97% |
| Mar 31, 2018 | -26.36% |
| Dec 31, 2017 | -29.97% |
| Dec 31, 2016 | -38.47% |